Literature DB >> 2940856

Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy.

R B Devereux, P N Casale, P Kligfield, R R Eisenberg, D Miller, E Campo, D R Alonso.   

Abstract

To determine which M-mode echocardiographic (echo) measurement best detects left ventricular (LV) hypertrophy, the sensitivity and specificity of upper normal limits of echo LV anatomic measurements (previously shown to have 97% specificity in living normal subjects) were tested in 60 necropsied patients with anatomic hypertrophy and in 28 necropsied patients with normal left ventricles. The prevalence of hypertrophy by each echo criterion was determined in 165 living patients with systemic hypertension, mitral regurgitation or dilated cardiomyopathy. The best separation between patients with normal vs increased necropsy LV mass was obtained using sex-specific echo LV mass index criteria (overall accuracy = 73 of 88 patients, 83%). Lower overall accuracies for separation of patients with and without hypertrophy were observed for echo cross-sectional area (59 of 88 patients, 67%; p less than 0.05 vs LV mass index) and indexes of LV wall thickness (39 to 51%, p less than 0.001). Among 113 living patients with moderate or severe hypertension, mitral regurgitation or dilated cardiomyopathy, LV mass index was increased in 73%, cross-sectional area index in 58% (p less than 0.02 vs LV mass index), and posterior wall thickness, septal thickness and relative wall thickness in only 11 to 32% (all p less than 0.001 vs LV mass index). Thus, an M-mode echo LV mass index of more than 134 g/m2 in men and more than 110 g/m2 in women detects concentric and eccentric LV hypertrophy accurately by comparison with necropsy and clinical reference standards; cross-sectional area is slightly less useful; and other M-mode echo criteria of LV hypertrophy perform too poorly to be clinically applicable.

Entities:  

Mesh:

Year:  1986        PMID: 2940856     DOI: 10.1016/0002-9149(86)90224-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.

Authors:  Mohammed Fakhry Abdul-Mohsen
Journal:  J Saudi Heart Assoc       Date:  2012-06-12

2.  Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.

Authors:  Chahinda Ghossein-Doha; Marc Spaanderman; Sander M J van Kuijk; Abraham A Kroon; Tammo Delhaas; Louis Peeters
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

3.  Left ventricular mass changes with nicardipine therapy in essential hypertension.

Authors:  P Gosse; P Lacroix; R Roudaut; M Dallocchio
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

4.  A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.

Authors:  Cesar Luiz Boguszewski; Carlos Mauricio Correa dos Santos; Kelly Suga Sakamoto; Lilian Cassia Marini; Admar Moraes de Souza; Monalisa Azevedo
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

5.  Prognostic evaluation of patients after myocardial infarction: incremental value of sestamibi single-photon emission computed tomography and echocardiography.

Authors:  P Zanco; A Zampiero; A Favero; N Borsato; F Chierichetti; D Rubello; G Ferlin
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

6.  Left ventricular dynamics after aortic valve replacement: a long-term, combined radionuclide angiographic and ultrasonographic study.

Authors:  C S Masotti; P Bonfranceschi; G Rusticali; F Rusticali; A Pierangeli
Journal:  Tex Heart Inst J       Date:  1992

7.  Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese.

Authors:  Zhuofeng Lin; Zhihong Zhou; Yanlong Liu; Qi Gong; Xinxin Yan; Jian Xiao; Xiaojie Wang; Shaoqiang Lin; Wenke Feng; Xiaokun Li
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

8.  Relation of left ventricular hypertrophy to regional cerebral blood flow: single photon emission computed tomography abnormalities in essential hypertension.

Authors:  Cristina Sierra; Alejandro de la Sierra; Francisco Lomeña; Juan Carlos Paré; María Larrousse; Antonio Coca
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

9.  Plasma fibulin-1 is linked to restrictive filling of the left ventricle and to mortality in patients with aortic valve stenosis.

Authors:  Jordi S Dahl; Jacob E Møller; Lars Videbæk; Mikael K Poulsen; Torsten R Rudbæk; Patricia A Pellikka; W Scott Argraves; Lars Melholt Rasmussen
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

10.  N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease.

Authors:  Jung Eun Lee; So Yeon Choi; Wooseong Huh; Seong Woo Park; Dae Joong Kim; Ha Young Oh; Yoon-Goo Kim
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.